2018 American Transplant Congress
Impact of Donation after Cardiac Death Allografts on Outcome Following Liver Transplantation for Fulminant Hepatic Failure: An Analysis of the UNOS Database
Scarcity of donor organs in liver transplantation (LT) has necessitated consideration of extended criteria donors (ECDs), including donation after cardiac death (DCD) donors. The narrow…2018 American Transplant Congress
Outcomes of Moderately Macrosteatotic Liver Allografts
Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.
Objectives: Liver transplantation remains the only effective long-term treatment option for patients with end-stage liver disease (ESLD). Organs available for ESLD patients are scarce and…2018 American Transplant Congress
Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis
Liver allocation for transplant candidates with hepatocellular carcinoma is limited by OPTN policy to patients whose tumors remain within size limits defined by Milan criteria.…2018 American Transplant Congress
Sustained Improvement in Patient Reported Outcomes 10 Years after Liver Transplantation by Protocol Longitudinal Assessment of Health Related Quality of Life
Purpose: Data on patient (pt) reported outcomes, especially beyond the first year after liver transplantation (LT) are scarce. We examined changes in health related quality…2018 American Transplant Congress
Ethnic and Age Disparities in Outcomes among Liver Transplant Waitlist Candidates
1University of Alabama at Birmingham, Birmingham; 2Department of Veterans Affairs, Washington DC.
Background: Despite the increasing prevalence of end-stage liver disease (ESLD) in older adults, there is no consensus to determine suitability for liver transplantation (LT) in…2018 American Transplant Congress
Impact of Early Corticosteroid Treatment in Patients with Indeterminate Acute Severe Hepatitis
Background and Aims: Discrimination of acute severe autoimmune hepatitis AIH and drug induced liver injury in patients with indeterminate acute severe Hepatitis is challenging. Early…2018 American Transplant Congress
Impact of Fluconazole Prophylaxis on Fungal Infections in Liver Transplant Recipients
1Lahey Hospital and Medical Center, Burlington, MA; 2Emory University Hospital, Atlanta, GA.
The purpose of this study was to assess if utilizing fluconazole for prophylaxis of invasive fungal infections (IFIs) in high risk liver transplant recipients is…2018 American Transplant Congress
Serum Beta-(1,3)-D-Glucan as a Case-Finding Tool during an Outbreak of Pneumocystitis jirovecii Pneumonia in Abdominal Transplant Patients
Division of Infectious Diseases, Montefiore Medical Center, Bronx, NY.
Background: Pneumocystis jirovecii pneumonia(PJP) in solid organ transplant (SOT) recipients carries significant morbidity and mortality. There is mounting evidence for ongoing risk of PJP in…2018 American Transplant Congress
Comparison of Pure Laparoscopic vs Open Living Donor Right Hepatectomy
Department of Surgery, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
Background With the development of laparoscopic skills, its application has expanded in living donor liver transplantation. However, due to technical difficulties, pure laparoscopic donor hepatectomy…2018 American Transplant Congress
The Grade of Pre-Transplant Portal Vein Thrombosis in Liver Transplant Recipients Impacts Graft and Patient Survival
Henry Ford Transplant Institute, Henry Ford Health System, Detroit, MI.
Background: Portal vein thrombosis (PVT) in the pre-transplant (pretx) setting makes liver transplantation technically challenging and is also known to affect post transplant outcomes. Few…
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 180
- Next Page »